SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-047154
Filing Date
2019-02-21
Accepted
2019-02-21 17:22:02
Documents
3
Period of Report
2019-02-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d706276d8k.htm 8-K 42688
2 EXHIBIT 3.1 d706276dex31.htm EX-3.1 5403
3 EXHIBIT 99.1 d706276dex991.htm EX-99.1 15494
  Complete submission text file 0001193125-19-047154.txt   65082
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 19622958
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences